Galenica Sante Ag Stock Return On Asset
| GALE Stock | CHF 70.55 0.55 0.79% |
Galenica Sante AG fundamentals help investors to digest information that contributes to Galenica Sante's financial success or failures. It also enables traders to predict the movement of Galenica Stock. The fundamental analysis module provides a way to measure Galenica Sante's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Galenica Sante stock.
Galenica |
Galenica Sante AG Company Return On Asset Analysis
Galenica Sante's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Current Galenica Sante Return On Asset | 0.0492 |
Most of Galenica Sante's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Galenica Sante AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
| Competition |
Based on the latest financial disclosure, Galenica Sante AG has a Return On Asset of 0.0492. This is 100.56% lower than that of the Healthcare sector and 100.21% lower than that of the Biotechnology industry. The return on asset for all Switzerland stocks is 135.14% lower than that of the firm.
Galenica Return On Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Galenica Sante's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Galenica Sante could also be used in its relative valuation, which is a method of valuing Galenica Sante by comparing valuation metrics of similar companies.Galenica Sante is currently under evaluation in return on asset category among related companies.
Galenica Fundamentals
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0492 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 4.26 B | |||
| Shares Outstanding | 49.64 M | |||
| Shares Owned By Insiders | 0.17 % | |||
| Shares Owned By Institutions | 49.77 % | |||
| Price To Earning | 16.37 X | |||
| Price To Book | 3.16 X | |||
| Price To Sales | 0.94 X | |||
| Revenue | 3.83 B | |||
| Gross Profit | 427.92 M | |||
| EBITDA | 305.98 M | |||
| Net Income | 167.68 M | |||
| Cash And Equivalents | 164.98 M | |||
| Cash Per Share | 2.13 X | |||
| Total Debt | 579.88 M | |||
| Debt To Equity | 43.80 % | |||
| Current Ratio | 1.77 X | |||
| Book Value Per Share | 23.35 X | |||
| Cash Flow From Operations | 333.1 M | |||
| Earnings Per Share | 3.45 X | |||
| Target Price | 70.0 | |||
| Number Of Employees | 5.52 K | |||
| Beta | 0.19 | |||
| Market Capitalization | 3.74 B | |||
| Total Asset | 2.57 B | |||
| Z Score | 4.6 | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 2.57 B | |||
| Last Dividend Paid | 2.1 |
About Galenica Sante Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Galenica Sante AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Galenica Sante using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Galenica Sante AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Galenica Sante AG. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Galenica Stock analysis
When running Galenica Sante's price analysis, check to measure Galenica Sante's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Galenica Sante is operating at the current time. Most of Galenica Sante's value examination focuses on studying past and present price action to predict the probability of Galenica Sante's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Galenica Sante's price. Additionally, you may evaluate how the addition of Galenica Sante to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |